Objective: To assess the economic burden of temporary ureteral stenting. Methods: The German version of the ureteral stent symptom questionnaire was completed by 74 patients with unilateral inserted indwelling stents. Cost accounting was performed considering the costs of ureteral stents, drugs, consultation of healthcare professionals, hospitalization, stent extraction and work incapacity due to stent-related problems. Results: Total costs arising from stent-related problems amounted to US dollars (USD) 133,355, median USD 455 (113-11,948) for the entire stent indwelling time, and USD 15 (4-398) per patient per day. Costs (USD total/median (range)) arose mainly from work incapacity (104,154/0 (0-11, 498)), followed by healthcare professional consultation (9,177/0 (0-612)), drug costs (8,736/111 (0-427)), stent material (8,390/113), stent removal (2,235/0 (0-1,769)) and outpatient hospital care (663/0 (0-663)). Most patients also showed a reduced capacity for work due to symptoms associated with indwelling stents. Conclusion: The economic burden of morbidity associated with indwelling ureteral stents is considerably high and should be taken into account when performing ureteral stenting, especially in cases where it is not strictly indicated and when stent removal is scheduled.

Keywords:
Ureter, Stents, Urinary tract, Cost of illness, Drug costs
1.
Tauber V, Wohlmuth M, Hochmuth A, Schimetta W, Krause FS: Efficacy management of urolithiasis: flexible ureteroscopy versus extracorporeal shockwave lithotripsy. Urol Int 2015;95:324-328.
2.
Joshi HB, Stainthorpe A, Keeley FX Jr, MacDonagh R, Timoney AG: Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol 2001;15:151-154.
3.
Leibovici D, Cooper A, Lindner A, et al: Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J 2005;7:491-494.
4.
Abt D, Warzinek E, Schmid HP, Haile SR, Engeler DS: Influence of patient education on morbidity caused by ureteral stents. Int J Urol 2015;27:679-683.
5.
Reeves P, Irwin D, Kelleher C, et al: The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006;50:1050-1057.
6.
Parise H, Laliberte F, Lefebvre P, et al: Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers. J Neurol Sci 2013;330:71-77.
7.
Weiss KB, Gergen PJ, Hodgson TA: An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-866.
8.
Ibrahim HM, Al-Kandari AM, Shaaban HS, Elshebini YH, Shokeir AA: Role of ureteral stenting after uncomplicated ureteroscopy for distal ureteral stones: a randomized, controlled trial. J Urol 2008;180:961-965.
9.
Shigemura K, Yasufuku T, Yamanaka K, Yamahsita M, Arakawa S, Fujisawa M: How long should double J stent be kept in after ureteroscopic lithotripsy? Urol Res 2012;40:373-376.
10.
Documed: Arzneimittel-Kompendium der Schweiz, 2015.
11.
Tarifvertrag (LOA IV): Schweizerischen Apothekerverband (pharmaSuisse) and santésuisse - Die Schweizer Krankenversicherer (santésuisse). Endversion vom, 2009.
12.
Sozialversicherung Bf: TARMED: einheitliche Arzttarifstruktur genehmigt. BSV-Faktenblatt/Medienkonferenz vom, 2002.
13.
Bundesamt für Statistik, Schweizerische Lohnstrukturerhebung. Medienmitteilung vom, 2014.
14.
Mullahy J: Specification and testing of some modified count data models. J Econom 1986;33:341-365.
15.
Team RC: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2014.
16.
Jackman S: pscl: Classes and Methods for R Developed in the Political Science Computational Laboratory, Stanford University. Stanford, Department of Political Science, Stanford University, R Package Version 149, 2015.
17.
Zeileis A, Kleiber C, Jackman S: Regression models for count data in r. J Stat Softw 2008;27:1-25.
18.
Bloomberg Currency Converter. http://www.bloombergcom/markets/currencies/currency-converter/.
19.
Giannarini G, Keeley FX Jr, Valent F, et al: Predictors of morbidity in patients with indwelling ureteric stents: results of a prospective study using the validated ureteric stent symptoms questionnaire. BJU Int 2011;107:648-654.
20.
Irani J, Siquier J, Pires C, Lefebvre O, Dore B, Aubert J: Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int 1999;84:276-279.
21.
Abt D, Mordasini L, Warzinek E, et al: Is intravesical stent position a predictor of associated morbidity? Korean J Urol 2015;56:370-378.
22.
Walker NA, Bultitude MF, Brislane K, Thomas K, Glass JM: Management of stent symptoms: what a pain! BJU Int 2014;114:797-798.
23.
Hutchinson A, Bentzen, Konig-Zahn C: Cross Cultural Health Outcome Assessment: A User's Guide. Ruinen, European Research Group on Health Outcomes, 1996.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.